|
[1]
|
Genitsaridi, I., Salpea, P., Salim, A., et al. (2026) 11th Edition of the IDF Diabetes Atlas: Global, Regional, and National Diabetes Prevalence Estimates for 2024 and Projections for 2050. The Lancet Diabetes & Endocrinology, 14, 149-156.
|
|
[2]
|
Xu, Y., Lu, J., Li, M., Wang, T., Wang, K., Cao, Q., et al. (2024) Diabetes in China Part 1: Epidemiology and Risk Factors. The Lancet Public Health, 9, e1089-e1097. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Williams, B.A., Blankenship, J.C., Voyce, S., Cordova, J.M., Gandhi, P. and Shetty, S.S. (2021) Quantifying the Risk Continuum for Cardiovascular Death in Adults with Type 2 Diabetes. Canadian Journal of Diabetes, 45, 650-658.e2. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Sibal, L., Sibal, L., Agarwal, and Home, P. (2011) Carotid Intima-Media Thickness as a Surrogate Marker of Cardiovascular Disease in Diabetes. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 4, 23-34. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Saleh, C. (2024) Carotid Intima Media Thickness and Multiple Sclerosis. Multiple Sclerosis and Related Disorders, 89, Article 105752. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Jensen-Urstad, K.J., Reichard, P.G., Rosfors, J.S., Lindblad, L.E.L. and Jensen-Urstad, M.T. (1996) Early Atherosclerosis Is Retarded by Improved Long-Term Blood Glucose Control in Patients with Iddm. Diabetes, 45, 1253-1258. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Finn, A.V., Kolodgie, F.D. and Virmani, R. (2010) Correlation between Carotid Intimal/Medial Thickness and Atherosclerosis: A Point of View from Pathology. Arteriosclerosis, Thrombosis, and Vascular Biology, 30, 177-181. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Bruzzese, V., Marrese, C., Zullo, A., Hassan, C., Ridola, L., Izzo, A., et al. (2011) Carotid Artery Intima-Media Thickness in Patients with Autoimmune Connective Tissue Diseases: A Case-Control Study. Internal and Emergency Medicine, 8, 713-716. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Mussbacher, M., Schossleitner, K., Kral-Pointner, J.B., Salzmann, M., Schrammel, A. and Schmid, J.A. (2022) More than Just a Monolayer: The Multifaceted Role of Endothelial Cells in the Pathophysiology of Atherosclerosis. Current Atherosclerosis Reports, 24, 483-492. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Chee, Y.J., Dalan, R. and Cheung, C. (2025) The Interplay between Immunity, Inflammation and Endothelial Dysfunction. International Journal of Molecular Sciences, 26, Article 1708. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Yang, D.R., Wang, M.Y., Zhang, C.L. and Wang, Y. (2024) Endothelial Dysfunction in Vascular Complications of Diabetes: A Comprehensive Review of Mechanisms and Implications. Frontiers in Endocrinology, 15, Article 1359255. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Wu, L., Xu, J., Wu, C., et al. (2025) Advances in Molecular Mechanisms and Precision Interventions of Cardiovascular Injuries Related to Glucose and Lipid Metabolism Disorders. Reviews in Cardiovascular Medicine, 26, Article 42406.
|
|
[13]
|
刘丽媛, 张誉洋, 王海昌. 晚期糖基化终末产物的血管损伤效应及机制[J]. 中华老年心脑血管病杂志, 2015, 17(6): 660-662.
|
|
[14]
|
Wang, L., Chen, Q., Zhang, L., et al. (2025) Correlation between IL-6, Chemerin, Lipid Ratio and Insulin Resistance in Obese Patients with Type 2 Diabetes Mellitus. Journal of Preventive Medicine and Public Health, 36, 45-50.
|
|
[15]
|
Vigili de Kreutzenberg, S., Tiengo, A. and Avogaro, A. (2009) Cerebrovascular Disease in Diabetes Mellitus: The Role of Carotid Intima-Media Thickness. Nutrition, Metabolism and Cardiovascular Diseases, 19, 667-673. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Beatty, C., Richardson, K.P., Tran, P.M.H., et al. (2024) Multiplex Analysis of Inflammatory Proteins Associated with Risk of Coronary Artery Disease in Type-1 Diabetes Patients. Clinical Cardiology, 47, e24143.
|
|
[17]
|
骆莹莹, 姚树桐, 王大新, 等. 氧化应激在动脉粥样硬化发生发展中作用的研究新进展[J]. 中国介入心脏病学杂志, 2013, 21(1): 46-50.
|
|
[18]
|
Luc, K., Schramm-Luc, A., Guzik, T.J. and Mikolajczyk, T.P. (2019) Oxidative Stress and Inflammatory Markers in Prediabetes and Diabetes. Journal of Physiology and Pharmacology, 70, 809-824.
|
|
[19]
|
Ma, Y., Liu, H., Wang, Y., Xuan, J., Gao, X., Ding, H., et al. (2022) Roles of Physical Exercise-Induced miR-126 in Cardiovascular Health of Type 2 Diabetes. Diabetology & Metabolic Syndrome, 14, Article No. 169. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Maratni, N.P.T., Saraswati, M.R., Ayu Dewi, N.N. and Suastika, K. (2023) miRNA146a and Diabetes-Related Complications: A Review. Current Diabetes Reviews, 19, e141022209958. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Wang, W., Liu, Y., Li, Y., Xu, Q., Zhu, M., Cui, J., et al. (2026) Chinese Medicine and Intermittent Fasting Integration Therapy Attenuate Diabetic Vascular Calcification via miR21-5p/Tpm1-Mediated Osteogenic Differentiation of VSMCs. Acta Pharmaceutica Sinica B, 16, 352-370. [Google Scholar] [CrossRef]
|
|
[22]
|
Al Bataineh, A., Vamsi, B., El-Abd, M. and Doppala, B.P. (2025) Kolmogorov-Arnold Networks for Predicting Carotid Intima-Media Thickness in Cardiovascular Risk Assessment. Scientific Reports, 15, Article No. 32108. [Google Scholar] [CrossRef]
|
|
[23]
|
Pathakota, S.R., Durgaprasad, R., Velam, V., Ay, L. and Kasala, L. (2020) Correlation of Coronary Artery Calcium Score and Carotid Artery Intima-Media Thickness with Severity of Coronary Artery Disease. Journal of Cardiovascular and Thoracic Research, 12, 78-83.
|
|
[24]
|
Lorenz, M.W., Price, J.F., Robertson, C., Bots, M.L., Polak, J.F., Poppert, H., et al. (2015) Carotid Intima-Media Thickness Progression and Risk of Vascular Events in People with Diabetes: Results from the PROG-IMT Collaboration. Diabetes Care, 38, 1921-1929. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Lu, J., Ma, X., Shen, Y., et al. (2020) Time in Range Is Associated with Carotid Intima-Media Thickness in Type 2 Diabetes. Diabetes Technology & Therapeutics, 22, 72-78.
|
|
[26]
|
贾明理, 曾彬. 颈动脉内膜中层厚度对2型糖尿病伴发冠心病患者的诊断价值[J]. 临床荟萃, 2014, 29(9): 982-985.
|
|
[27]
|
Della-Morte, D., Ricordi, C., Guadagni, F. and Rundek, T. (2013) Measurement of Subclinical Carotid Atherosclerosis May Help in Predicting Risk for Stroke in Patients with Diabetes. Metabolic Brain Disease, 28, 337-339. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Matsumoto, K., Sera, Y., Nakamura, H., Ueki, Y. and Miyake, S. (2002) Correlation between Common Carotid Arterial Wall Thickness and Ischemic Stroke in Patients with Type 2 Diabetes Mellitus. Metabolism, 51, 244-247. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Cao, J., Zhou, D., Yao, Z., Zeng, Y., Zheng, J., Tang, Y., et al. (2024) Insulin Resistance, Vulnerable Plaque and Stroke Risk in Patients with Carotid Artery Stenosis. Scientific Reports, 14, Article No. 30453. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Yoon, H.J., Kim, K.H., Park, H., Cho, J.Y., Hong, Y.J., Park, H.W., et al. (2017) Carotid Plaque Rather than Intima-Media Thickness as a Predictor of Recurrent Vascular Events in Patients with Acute Ischemic Stroke. Cardiovascular Ultrasound, 15, Article No. 19. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Polak, J.F., Pencina, M.J., Pencina, K.M., O’Donnell, C.J., Wolf, P.A. and D’Agostino, R.B. (2011) Carotid-Wall Intima-Media Thickness and Cardiovascular Events. New England Journal of Medicine, 365, 213-221. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Katakami, N., Mita, T., Gosho, M., Takahara, M., Irie, Y., Yasuda, T., et al. (2018) Clinical Utility of Carotid Ultrasonography in the Prediction of Cardiovascular Events in Patients with Diabetes: A Combined Analysis of Data Obtained in Five Longitudinal Studies. Journal of Atherosclerosis and Thrombosis, 25, 1053-1066. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Zhang, M., Wen, X., Zhou, C., Huang, J. and He, Y. (2019) Carotid Intima-Media Thickness and Plaques in Internal Carotid Artery as Surrogate Markers of Lower Limb Arterial Lesions in Chinese Patients with Diabetic Foot. Brazilian Journal of Medical and Biological Research, 52, e8432. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Gacoń, J., Przewłocki, T., Podolec, J., et al. (2019) Prospective Study on the Prognostic Value of Repeated Carotid Intima-Media Thickness Assessment in Patients with Coronary and Extra Coronary Steno-Occlusive Arterial Disease. Polish Archives of Internal Medicine, 129, 12-21.
|
|
[35]
|
Mashaba, R.G., Phoswa, W., Maimela, E., Lebelo, S., Modjadji, P. and Mokgalaboni, K. (2024) Systematic Review and Meta-Analysis Assessing the Status of Carotid Intima-Media Thickness and Lipid Profiles in Type 2 Diabetes Mellitus. BMJ Open, 14, e087496. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Mashaba, R.G., Phoswa, W., Maimela, E. and Mokgalaboni, K. (2024) Association of Carotid Intima-Media Thickness and Dyslipidaemia in Patients with Type 2 Diabetes: A Protocol for Systematic Review and Meta-Analysis. BMJ Open, 14, e079209. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Sun, Y.P., Cai, Y.Y., Li, H.M., et al. (2015) Increased Carotid Intima-Media Thickness (CIMT) Levels in Patients with Type 1 Diabetes Mellitus (T1DM): A Meta-Analysis. Journal of Diabetes and its Complications, 29, 724-730. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
郭兴, 李金生, 王星. 超声评价中老年冠心病患者心外膜脂肪层厚度与颈动脉血管弹性的相关性[J]. 中国动脉硬化杂志, 2023, 31(9): 785-790.
|
|
[39]
|
赵宏波, 冯硕, 杨旭, 等. 远程超声在基层临床疾病筛查与诊断中的应用[J]. 中国超声医学杂志, 2024, 40(9): 1054-1057.
|
|
[40]
|
李玲玲. 从血液流变学及CIMT角度评价参芪复方序贯疗法防止2型糖尿病大血管损伤的研究[D]: [硕士学位论文]. 成都: 成都中医药大学, 2019.
|
|
[41]
|
吴奇红. 参芪降糖颗粒辅助治疗2型糖尿病伴代谢综合征临床研究[J]. 新中医, 2023, 55(13): 85-89.
|
|
[42]
|
任慧. 参芪降糖颗粒辅助二甲双胍对2型糖尿病患者血糖控制及胰岛素抵抗指数的影响[J]. 实用中西医结合临床, 2021, 21(6): 19-20.
|
|
[43]
|
张菊红. 参芪降糖颗粒联合盐酸二甲双胍治疗II型糖尿病疗效分析[J]. 内蒙古中医药, 2025, 44(11): 23-25.
|
|
[44]
|
魏聪聪, 朱明丹, 杜武勋, 等. 芪参益气滴丸临床应用研究进展[J]. 西部中医药, 2011, 24(10): 102-106.
|
|
[45]
|
姚晶尧. 《通络药物系统干预心血管事件链专家共识》发布[J]. 中医药管理杂志, 2025, 33(17): 40.
|
|
[46]
|
陈美芳, 陈凯伟. 血府逐瘀汤对2型糖尿病早期血瘀证患者胰岛素抵抗、胰岛β细胞分泌功能及微炎症状态的影响[J]. 临床合理用药, 2025, 18(13): 30-33.
|
|
[47]
|
Liu, L., Liu, J.X., Guo, H. and Ren, J.X. (2017) Recent Advances on Pericytes in Microvascular Dysfunction and Traditional Chinese Medicine Prevention. China Journal of Chinese Materia Medica, 42, 3072-3077.
|
|
[48]
|
Zhang, Y., Zhang, S., Zhang, Z., Cao, Z., Bai, X., Zhang, S., et al. (2025) Mechanisms of Xuefu Zhuyu Decoction in Treating Diabetic Kidney Disease-Induced Renal Fibrosis: UPLC-Q/TOF-MS, Network Pharmacology, and Experimental Validation. The Korean Journal of Physiology & Pharmacology, 29, 571-597. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Ye, X., Ren, H., Jiang, T., Zhang, T. and Li, G. (2020) Effect of Diabetes Blood-Stasis Syndrome and Xuefu Zhuyu Decoction on ROS-ERK1/2 Signaling Pathway in Rat Retina Müller Cells. Cytotechnology, 72, 303-314. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Song, C., Zhu, Z., Liu, M., Yang, W., Bai, X. and Nan, Z. (2022) Clinical Efficacy and Safety of Xuefu Zhuyu Decoction in the Treatment of Diabetic Kidney Disease: A Protocol for Systematic Review and Meta-Analysis. Medicine, 101, e32359. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Huang, Q., Ni, H.X. and Shao, G.M. (2003) Effect of Chinese Herbal Medicine for Activating Blood Circulation to Remove Stasis on CD11b/CD18 Expression in Patients with Diabetes Mellitus Type 2. Chinese Journal of Integrated Traditional and Western Medicine, 23, 430-432.
|
|
[52]
|
Wang, W., Li, Y., Zhu, M., Xu, Q., Cui, J., Liu, Y., et al. (2025) Danlian-Tongmai Formula Improves Diabetic Vascular Calcification by Regulating CCN3/NOTCH Signal Axis to Inhibit Inflammatory Reaction. Frontiers in Pharmacology, 15, Article 1510030. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
林建勇, 邱鹏远, 肖宏燕. 超声评估颈动脉狭窄患者血流动力学参数与认知功能的相关性分析[J]. 影像研究与医学应用, 2026, 10(1): 61-63.
|
|
[54]
|
符杰, 邓红艳, 李玉凯, 等. 丹参酮IIA对2型糖尿病合并冠心病患者的临床疗效及TLR4/NF-κB通路的影响[J]. 中南医学科学杂志, 2025, 53(1): 53-57.
|
|
[55]
|
Zheng, S., Zhang, M., Wang, W., Zhang, Q. and Zhang, N. (2025) Effects and Safety of Salvia Miltiorrhiza on the Improvement of Renal Function, Inflammatory Factors, and Vascular Endothelium in Patients with Diabetic Kidney Disease: A Meta-Analysis and Systematic Review. Frontiers in Pharmacology, 16, Article 1556368. [Google Scholar] [CrossRef]
|
|
[56]
|
Heng, Y.Y., Shang, H.J., Zhang, X.Z. and Wei, W. (2023) Sodium Tanshinone IIA Sulfonate Ameliorates Neointima by Protecting Endothelial Progenitor Cells in Diabetic Mice. BMC Cardiovascular Disorders, 23, Article No. 446. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
凌婧. 川芎挥发油对大鼠脑缺血再灌注损伤的保护作用及其机制研究[D]: [硕士学位论文]. 成都: 四川大学, 2006.
|
|
[58]
|
李芳芳, 张琪. 川芎嗪对血管内皮损伤的保护作用机制研究进展[J]. 中国医药导报, 2020, 17(8): 25-28.
|
|
[59]
|
Sha, W., Zhao, B., Wei, H., Yang, Y., Yin, H., Gao, J., et al. (2023) Astragalus Polysaccharide Ameliorates Vascular Endothelial Dysfunction by Stimulating Macrophage M2 Polarization via Potentiating Nrf2/HO-1 Signaling Pathway. Phytomedicine, 112, Article 154667. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Han, W., Wang, Z., Guo, H., Wang, M., Cao, L. and Sun, G. (2025) Ginsenoside RC Inhibits Diabetic Cardiomyopathy by Reducing Lipotoxicity through the Adiponectin and Autophagy Pathways. Phytomedicine, 150, Article 157615. [Google Scholar] [CrossRef]
|
|
[61]
|
谢丽钰, 卢健棋, 罗宇东, 等. 桃仁-红花药对及其活性成分治疗心血管疾病作用机制的研究进展[J]. 时珍国医国药, 2025, 36(20): 3930-3935.
|
|
[62]
|
Yuan, W., Zhang, Y., Ge, Y., Yan, M., Kuang, R. and Zheng, X. (2008) Astragaloside IV Inhibits Proliferation and Promotes Apoptosis in Rat Vascular Smooth Muscle Cells under High Glucose Concentration in Vitro. Planta Medica, 74, 1259-1264. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Liang, Y., Chen, B., Liang, D., Quan, X., Gu, R., Meng, Z., et al. (2023) Pharmacological Effects of Astragaloside IV: A Review. Molecules, 28, Article 6118. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Wei, W., Heng, Y.Y., Wu, F.F., et al. (2024) Sodium Tanshinone IIA Sulfonate Alleviates Vascular Senescence in Diabetic Mice by Modulating the A20-NF-κB-NLRP3 Inflammasome-Catalase Pathway. Scientific Reports, 14, Article No. 17665. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
Liu, C., Zhou, M., Hu, Q., Cao, Y., Wen, J., Zhang, X., et al. (2025) Integrating Untargeted Metabolomics Revealed Ferulic Acid Treatment on Endothelial Progenitor Cells Mediated Vascular Dysfunction Following Diabetic Wound. The FASEB Journal, 39, e70832. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Zhou, W., Asif, A., Situ, C., Wang, J. and Hao, H. (2025) Multiple Target and Regulatory Pathways of Berberine. Phytomedicine, 146, Article 157030. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Yang, S., Li, D., Yu, Z., Li, Y. and Wu, M. (2021) Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota. Frontiers in Pharmacology, 12, Article 709629. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
Zhu, Q., Kang, J., Xu, G., Li, J., Zhou, H. and Liu, Y. (2020) Traditional Chinese Medicine Shenqi Compound to Improve Lower Extremity Atherosclerosis of Patients with Type 2 Diabetes by Affecting Blood Glucose Fluctuation: Study Protocol for a Randomized Controlled Multicenter Trial. Medicine, 99, e19501. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Agarwal, A., Mustafa, R., Manja, V., Agoritsas, T., Macdonald, H., Li, S., et al. (2025) Cardiovascular, Kidney Related, and Weight Loss Effects of Therapeutics for Type 2 Diabetes: A Living Clinical Practice Guideline. British Medical Journal, 390, e082071. [Google Scholar] [CrossRef] [PubMed]
|
|
[70]
|
Nelson, A.J., O’Brien, E.C., Kaltenbach, L.A., Green, J.B., Lopes, R.D., Morse, C.G., et al. (2022) Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease. JAMA Network Open, 5, e2148030. [Google Scholar] [CrossRef] [PubMed]
|
|
[71]
|
Aristizábal-Colorado, D., Corredor-Rengifo, D., Sierra-Castillo, S., López-Corredor, C., Vernaza-Trujillo, D., Weir-Restrepo, D., et al. (2025) A Decade of Progress in Type 2 Diabetes and Cardiovascular Disease: Advances in SGLT2 Inhibitors and GLP-1 Receptor Agonists—A Comprehensive Review. Frontiers in Endocrinology, 16, Article 1605746. [Google Scholar] [CrossRef] [PubMed]
|
|
[72]
|
王子钰, 王文婷, 徐仕晗, 等. “异病同治”视角下从血瘀论治糖尿病视网膜病变与冠心病的现代机制探析[J]. 中国实验方剂学杂志, 2024, 30(5): 197-205.
|
|
[73]
|
den Ruijter, H.M., Peters, S.A.E., Groenewegen, K.A., Anderson, T.J., Britton, A.R., Dekker, J.M., et al. (2013) Common Carotid Intima-Media Thickness Does Not Add to Framingham Risk Score in Individuals with Diabetes Mellitus: The USE-IMT Initiative. Diabetologia, 56, 1494-1502. [Google Scholar] [CrossRef] [PubMed]
|
|
[74]
|
Kota, S.K., Mahapatra, G.B., Kota, S.K., et al. (2013) Carotid Intima Media Thickness in Type 2 Diabetes Mellitus with Ischemic Stroke. Indian Journal of Endocrinology and Metabolism, 17, 716-722. [Google Scholar] [CrossRef] [PubMed]
|
|
[75]
|
Ling, J., Xie, Z., Luo, X., Hu, M., Glujovsky, D., Zhuang, J., et al. (2025) An Evidence Mapping Study Based on Systematic Reviews of Traditional Chinese Medicine (TCM) for Diabetic Retinopathy. Systematic Reviews, 14, Article No. 45. [Google Scholar] [CrossRef] [PubMed]
|
|
[76]
|
Dou, Z., Xia, Y., Zhang, J., Li, Y., Zhang, Y., Zhao, L., et al. (2021) Syndrome Differentiation and Treatment Regularity in Traditional Chinese Medicine for Type 2 Diabetes: A Text Mining Analysis. Frontiers in Endocrinology, 12, Article 728032. [Google Scholar] [CrossRef] [PubMed]
|
|
[77]
|
Jiang, M., Lu, C., Zhang, C., Yang, J., Tan, Y., Lu, A., et al. (2012) Syndrome Differentiation in Modern Research of Traditional Chinese Medicine. Journal of Ethnopharmacology, 140, 634-642. [Google Scholar] [CrossRef] [PubMed]
|
|
[78]
|
Li, M., Wen, G., Zhong, J. and Yang, P. (2022) Personalized Intelligent Syndrome Differentiation Guided by TCM Consultation Philosophy. Journal of Healthcare Engineering, 2022, 1-11. [Google Scholar] [CrossRef] [PubMed]
|
|
[79]
|
Li, J., Zhu, N., Wang, Y., Bao, Y., Xu, F., Liu, F., et al. (2023) Application of Metabolomics and Traditional Chinese Medicine for Type 2 Diabetes Mellitus Treatment. Diabetes, Metabolic Syndrome and Obesity, 16, 4269-4282. [Google Scholar] [CrossRef] [PubMed]
|
|
[80]
|
Li, E., Maunder, A., Liu, J., Pandey, C., Cave, A., O’Fee, A., et al. (2025) The Efficacy and Safety of Herbal Medicines for Glycaemic Control and Insulin Resistance in Individuals with Type 2 Diabetes: An Umbrella Review. BMC Complementary Medicine and Therapies, 25, Article No. 341. [Google Scholar] [CrossRef]
|
|
[81]
|
Gao, Y., Zhang, L., Zhang, F., Liu, R., Liu, L., Li, X., et al. (2024) Traditional Chinese Medicine and Its Active Substances Reduce Vascular Injury in Diabetes via Regulating Autophagic Activity. Frontiers in Pharmacology, 15, Article 1355246. [Google Scholar] [CrossRef] [PubMed]
|
|
[82]
|
Zhao, Y.L., Liao, J.B., Pang, P.P., et al. (2026) Pharmacological Advances in Multi-Targeted Strategies for Type 2 Diabetes Mellitus: A Systematic Perspective Based on Traditional Chinese Medicine. Frontiers in Pharmacology, 16, Article 1732134. [Google Scholar] [CrossRef]
|
|
[83]
|
Chen, C., Gao, H., Wei, Y. and Wang, Y. (2025) Traditional Chinese Medicine in the Prevention of Diabetes Mellitus and Cardiovascular Complications: Mechanisms and Therapeutic Approaches. Frontiers in Pharmacology, 16, 1511701. [Google Scholar] [CrossRef] [PubMed]
|